Sana Syed
0000-0003-0954-0583
Publication & Citation Trends
Publications
0 total
Tolebrutinib Versus Placebo in Non-relapsing Secondary Progressive Multiple Sclerosis: Efficacy and Safety Results from the Phase 3 HERCULES Trial (PL5.003)
Cited by 0
Semantic Scholar
3478 Baseline characteristics in the tolebrutinib phase 3 primary progressive multiple sclerosis perseus clinical trial
Cited by 0
Semantic Scholar
3591 Tolebrutinib versus placebo in non-relapsing secondary progressive multiple sclerosis: efficacy and safety results from the phase 3 HERCULES trial
Cited by 0
Semantic Scholar
Tolebrutinib Phase 2b Long-Term Extension Study: Two-Year Safety, MRI, and Clinical Efficacy Outcomes in Patients With Relapsing Multiple Sclerosis Patients.
Cited by 3
Semantic Scholar
154. Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results From the Phase 3 GEMINI 1 and 2 Trials
Cited by 7
Semantic Scholar
ECTRIMS 2024 – Late Breaking Oral Presentations
Cited by 9
Semantic Scholar
Research Topics
Child Nutrition and Water Access
(41)
Colorectal Cancer Screening and Detection
(33)
AI in cancer detection
(25)
Radiomics and Machine Learning in Medical Imaging
(18)
Inflammatory Bowel Disease
(16)
Affiliations
Aga Khan University
National Institute of Technology Warangal
Brigham and Women's Hospital
Mount Sinai Beth Israel
Boston Children's Hospital